Management

Catherine Moukheibir

Catherine Moukheibir

Independent Director

  • Current term until 2017

Catherine Moukheibir held C-level positions in several European biotech companies after an initial career in strategy consulting and investment banking in Boston and London. Her particular experience lies in aligning corporate and financial strategies appropriate to various stages of a biotech’s development, on the continuum from venture capital funding to public market or M&A. She is currently non-executive Chairman of MedDay Pharma sa, non-executive Board member and Chair of the Audit Committee at Zealand Pharma, non-executive Board member and member of the Audit Committee at Cerenis and Ablynx and Advisory Board member at the Imperial College Business School and the Yale School of Management. Catherine Moukheibir holds an MBA from Yale University.

 

< Back